Skip to main content

Verrica Pharmaceuticals Inc 10-Q for FY2024 Q3

Verrica Pharmaceuticals Inc. (VRCA)

10-Q 2024-11-05 For: 2024-09-30
View Original
Added on April 08, 2026

About this 10-Q

Verrica Pharmaceuticals Inc filed this 10-Q on November 5, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
-$1.78M
compared with $2.92M a year earlier
Net loss
$22.86M
compared with a net loss of $24.8M a year earlier
Diluted EPS
-$0.49
compared with -$0.54 a year earlier